PharmaEssentia: March 2026 Monthly Revenue NT$1.94 Billion (YoY +64.4%)
PharmaEssentia announced its March 2026 monthly revenue reached NT$1.94 billion, marking a substantial year-on-year increase of 64.4%. This strong performance highlights the company's robust growth within the biotechnology and medical industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 13, 2026 at 05:16 (12h 45m after Collected)
Company Code: 6446
Company Name: PharmaEssentia
Industry: Biotechnology and Medical Industry
Data Month: 2026-03
Monthly Revenue: NT$1,940,196 thousand (NT$1.94 billion)
Year-on-year change from same month last year: +64.4%
Company Name: PharmaEssentia
Industry: Biotechnology and Medical Industry
Data Month: 2026-03
Monthly Revenue: NT$1,940,196 thousand (NT$1.94 billion)
Year-on-year change from same month last year: +64.4%
FAQ
What was PharmaEssentia's revenue in March 2026?
PharmaEssentia's monthly revenue for March 2026 was NT$1.94 billion (NT$1,940,196 thousand).
How much did it increase compared to the same month last year?
It recorded a significant increase of 64.4% compared to the same month last year.
What industry does PharmaEssentia belong to?
PharmaEssentia belongs to the biotechnology and medical industry.